-
BD to Invest in Pre-Fillable Syringe Manufacturing Capacity
americanpharmaceuticalreview
December 21, 2020
BD announced plans to invest approximately $1.2 billion over a four-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing ...
-
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years
prnasia
December 03, 2020
BD, a leading global medical technology company, announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems ...
-
BD Receives FDA Approval for HPV Test with Extended Genotyping Capabilities
americanpharmaceuticalreview
July 29, 2020
BD has received approval for a pre-market approval (PMA) supplement from the U.S. Food and Drug Administration (FDA) for an expanded version of its BD Onclarity™ HPV Assay.
-
BD Partners with U.S. Govt. on $70M Vaccination Program
contractpharma
July 14, 2020
Company finalizes initial pandemic order for 50 million injection devices to support Operation Warp Speed vaccination program.
-
BD Announces Second FDA Emergency Use Authorization, CE Mark for COVID-19 Molecular Diagnostic
americanpharmaceuticalreview
April 16, 2020
BD announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for an additional molecular diagnostic test for COVID-19.
-
BD, BioGX Announce FDA Emergency Use Authorization for COVID-19 Diagnostic Test
americanpharmaceuticalreview
April 08, 2020
BD announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test that will enable hospitals to screen ...
-
Dense Breast Notifications May Not Be Having Intended Impact
drugs
December 31, 2019
While dense breast notifications (DBNs) are mandated legislatively in more than 35 states, they may not be having their intended impact ...
-
Particle Measuring Systems Announces Distribution Agreement with BD
americanpharmaceuticalreview
December 09, 2019
Particle Measuring Systems (PMS) has announced a distribution agreement with BD (Becton, Dickinson and company)...
-
BD Launches BD Intevia™ 1mL Two-step Disposable Autoinjector – A Robust Platform Device Combining Autoinjector and Pre-Fillable Syringe in One Integrated System
b3cnewswire
October 22, 2019
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of the BD Intevia™ 1mL two-step disposable autoinjector ...
-
BD to market its Venovo™ Venous Stent
biospectrumasia
March 19, 2019
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo™ venous stent, the first stent indicated to treat iliofemoral venous occlusive d